CPP
GSK icon

Crow Point Partners’s GSK GSK Stock Holding History

Crow Point Partners’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-501
Closed -$27K – 297
2016
Q3 		$27K Buy
+501
New +$27.5K ﹤0.01% 271
2015
Q3 		$42K Buy
864
+176
+26% +$9.16K 0.01% 228
2015
Q2 		$36K Buy
688
+480
+231% +$27K 0.01% 230
2015
Q1 		$12K Buy
+208
New +$11.9K ﹤0.01% 216
2014
Q3 		$11K Sell
192
-6,272
-97% -$385K ﹤0.01% 227
2014
Q2 		$432K Hold
6,464
– – 0.06% 132
2014
Q1 		$432K Buy
+6,464
New +$437K 0.06% 132

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Crow Point Partners's GSK Position: Q4 2016 in Review

Crow Point Partners sold out of GSK (GSK) in Q4 2016, closing a stake of 501 shares — an estimated $27K sold.

Crow Point Partners first reported a position in GSK in Q1 2014 and held it in 7 quarters. The position peaked at $432K in Q2 2014. 763 funds tracked by Wall St. Rank hold GSK as of Q4 2016.

  • Crow Point Partners reported no remaining GSK position as of Q4 2016 after selling out during the quarter.
  • Crow Point Partners sold 501 GSK shares in Q4 2016, an estimated $27K.
  • Crow Point Partners first reported a position in GSK in Q1 2014 and held it in 7 quarters.
  • Crow Point Partners's GSK position peaked at $432K in Q2 2014.
  • 763 funds tracked by Wall St. Rank held GSK as of Q4 2016.

Based on Crow Point Partners's 13F filing for Q4 2016, filed 15 Feb 2017.